Laparoscopic Intraperitoneal Port Placement for Optimally Cytoreduced Advanced Ovarian Cancer

Abstract Study objective To evaluate complications of intraperitoneal ports placed laparoscopically as a separate procedure after initial debulking surgery for ovarian, fallopian tube, or primary peritoneal cancer. Design A retrospective case series (Canadian Task Force Classification III). Setting...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of minimally invasive gynecology 2011-09, Vol.18 (5), p.629-633
Hauptverfasser: Janco, Jo Marie Tran, MD, Hacker, Michele R., ScD, MSPH, Konstantinopoulos, Panagiotis A., MD, Cannistra, Stephen A., MD, Awtrey, Christopher S., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 633
container_issue 5
container_start_page 629
container_title Journal of minimally invasive gynecology
container_volume 18
creator Janco, Jo Marie Tran, MD
Hacker, Michele R., ScD, MSPH
Konstantinopoulos, Panagiotis A., MD
Cannistra, Stephen A., MD
Awtrey, Christopher S., MD
description Abstract Study objective To evaluate complications of intraperitoneal ports placed laparoscopically as a separate procedure after initial debulking surgery for ovarian, fallopian tube, or primary peritoneal cancer. Design A retrospective case series (Canadian Task Force Classification III). Setting Inpatient, academic teaching institution. Patients Female patients of any age, at a single institution, undergoing laparoscopically-assisted intraperitoneal port placement after initial surgery for ovarian, fallopian tube, or primary peritoneal cancer from January 2001 through December 2009. Interventions Laparoscopically assisted intra-peritoneal port placement. Measurements/Main Results Thirty-three ports were successfully placed, with no conversions to laparotomy. Only 2 patients were unable to receive intraperitoneal chemotherapy, and there was 1 major complication (enterotomy) related to port placement. There were 6 cases of port dysfunction (17%); however, in 3 cases the port was replaced and subsequently functioned well. There were 2 cases of port infection necessitating port removal. The majority (81.8%) of patients were able to complete all planned cycles of intraperitoneal chemotherapy. Conclusion Based on the data from our institution, laparoscopic placement of an intraperitoneal port may be safely performed as a second procedure after initial surgery for stage III ovarian, fallopian tube, or primary peritoneal cancer and provides access for post-operative therapy.
doi_str_mv 10.1016/j.jmig.2011.06.005
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_885911512</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1553465011003244</els_id><sourcerecordid>885911512</sourcerecordid><originalsourceid>FETCH-LOGICAL-c410t-8a7fb7f0da598d8c9bfdbfbd3d6947507ef3bcd4033f9d8705db122003ff4a8e3</originalsourceid><addsrcrecordid>eNp9kc2LFDEQxYMo7rr6D3iQvnmatpL0J4iwDH4sDMyCepSQTiqSNt1pk_TA_PemmXUPHjxVFbz34P2KkNcUSgq0eTeW42R_lgwoLaEpAeon5JrWNd9VTdM_fdxruCIvYhwBeAvQPCdXjHbAm4Zdkx8Hucjgo_KLVcXdnIJcMNjkZ5SuuPchFfdOKpxwToXxoTguyU7SuXOxPycfUK8KdXGrT3LeluNJBivnYr-d4SV5ZqSL-Oph3pDvnz5-23_ZHY6f7_a3h52qKKRdJ1sztAa0rPtOd6ofjB7MoLlu-qqtoUXDB6Ur4Nz0umuh1gNlLPcxppId8hvy9pK7BP97xZjEZKNC5-SMfo2i6-qe0pqyrGQXpcqlY0AjlpD7hLOgIDaqYhQbVbFRFdCITDWb3jzEr8OE-tHyF2MWvL8IMJc8WQwiKosbEBtQJaG9_X_-h3_sytnZKul-4Rnj6NcwZ3yCisgEiK_bX7e3UpoRsKrifwBxY58i</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>885911512</pqid></control><display><type>article</type><title>Laparoscopic Intraperitoneal Port Placement for Optimally Cytoreduced Advanced Ovarian Cancer</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Janco, Jo Marie Tran, MD ; Hacker, Michele R., ScD, MSPH ; Konstantinopoulos, Panagiotis A., MD ; Cannistra, Stephen A., MD ; Awtrey, Christopher S., MD</creator><creatorcontrib>Janco, Jo Marie Tran, MD ; Hacker, Michele R., ScD, MSPH ; Konstantinopoulos, Panagiotis A., MD ; Cannistra, Stephen A., MD ; Awtrey, Christopher S., MD</creatorcontrib><description>Abstract Study objective To evaluate complications of intraperitoneal ports placed laparoscopically as a separate procedure after initial debulking surgery for ovarian, fallopian tube, or primary peritoneal cancer. Design A retrospective case series (Canadian Task Force Classification III). Setting Inpatient, academic teaching institution. Patients Female patients of any age, at a single institution, undergoing laparoscopically-assisted intraperitoneal port placement after initial surgery for ovarian, fallopian tube, or primary peritoneal cancer from January 2001 through December 2009. Interventions Laparoscopically assisted intra-peritoneal port placement. Measurements/Main Results Thirty-three ports were successfully placed, with no conversions to laparotomy. Only 2 patients were unable to receive intraperitoneal chemotherapy, and there was 1 major complication (enterotomy) related to port placement. There were 6 cases of port dysfunction (17%); however, in 3 cases the port was replaced and subsequently functioned well. There were 2 cases of port infection necessitating port removal. The majority (81.8%) of patients were able to complete all planned cycles of intraperitoneal chemotherapy. Conclusion Based on the data from our institution, laparoscopic placement of an intraperitoneal port may be safely performed as a second procedure after initial surgery for stage III ovarian, fallopian tube, or primary peritoneal cancer and provides access for post-operative therapy.</description><identifier>ISSN: 1553-4650</identifier><identifier>EISSN: 1553-4669</identifier><identifier>DOI: 10.1016/j.jmig.2011.06.005</identifier><identifier>PMID: 21803662</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Catheters, Indwelling ; Cisplatin - therapeutic use ; Fallopian Tube Neoplasms - drug therapy ; Fallopian Tube Neoplasms - pathology ; Fallopian Tube Neoplasms - surgery ; Female ; Humans ; Infusions, Parenteral ; Intraperitoneal chemotherapy ; Laparoscopy ; Laparoscopy - methods ; Middle Aged ; Neoplasm Staging ; Obstetrics and Gynecology ; Ovarian cancer ; Ovarian Neoplasms - drug therapy ; Ovarian Neoplasms - pathology ; Ovarian Neoplasms - surgery ; Paclitaxel - therapeutic use ; Peritoneal Neoplasms - drug therapy ; Peritoneal Neoplasms - pathology ; Peritoneal Neoplasms - surgery ; Peritoneum - surgery ; Retrospective Studies ; Surgery ; Treatment Outcome</subject><ispartof>Journal of minimally invasive gynecology, 2011-09, Vol.18 (5), p.629-633</ispartof><rights>AAGL</rights><rights>2011 AAGL</rights><rights>Copyright © 2011 AAGL. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c410t-8a7fb7f0da598d8c9bfdbfbd3d6947507ef3bcd4033f9d8705db122003ff4a8e3</citedby><cites>FETCH-LOGICAL-c410t-8a7fb7f0da598d8c9bfdbfbd3d6947507ef3bcd4033f9d8705db122003ff4a8e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1553465011003244$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21803662$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Janco, Jo Marie Tran, MD</creatorcontrib><creatorcontrib>Hacker, Michele R., ScD, MSPH</creatorcontrib><creatorcontrib>Konstantinopoulos, Panagiotis A., MD</creatorcontrib><creatorcontrib>Cannistra, Stephen A., MD</creatorcontrib><creatorcontrib>Awtrey, Christopher S., MD</creatorcontrib><title>Laparoscopic Intraperitoneal Port Placement for Optimally Cytoreduced Advanced Ovarian Cancer</title><title>Journal of minimally invasive gynecology</title><addtitle>J Minim Invasive Gynecol</addtitle><description>Abstract Study objective To evaluate complications of intraperitoneal ports placed laparoscopically as a separate procedure after initial debulking surgery for ovarian, fallopian tube, or primary peritoneal cancer. Design A retrospective case series (Canadian Task Force Classification III). Setting Inpatient, academic teaching institution. Patients Female patients of any age, at a single institution, undergoing laparoscopically-assisted intraperitoneal port placement after initial surgery for ovarian, fallopian tube, or primary peritoneal cancer from January 2001 through December 2009. Interventions Laparoscopically assisted intra-peritoneal port placement. Measurements/Main Results Thirty-three ports were successfully placed, with no conversions to laparotomy. Only 2 patients were unable to receive intraperitoneal chemotherapy, and there was 1 major complication (enterotomy) related to port placement. There were 6 cases of port dysfunction (17%); however, in 3 cases the port was replaced and subsequently functioned well. There were 2 cases of port infection necessitating port removal. The majority (81.8%) of patients were able to complete all planned cycles of intraperitoneal chemotherapy. Conclusion Based on the data from our institution, laparoscopic placement of an intraperitoneal port may be safely performed as a second procedure after initial surgery for stage III ovarian, fallopian tube, or primary peritoneal cancer and provides access for post-operative therapy.</description><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Catheters, Indwelling</subject><subject>Cisplatin - therapeutic use</subject><subject>Fallopian Tube Neoplasms - drug therapy</subject><subject>Fallopian Tube Neoplasms - pathology</subject><subject>Fallopian Tube Neoplasms - surgery</subject><subject>Female</subject><subject>Humans</subject><subject>Infusions, Parenteral</subject><subject>Intraperitoneal chemotherapy</subject><subject>Laparoscopy</subject><subject>Laparoscopy - methods</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Obstetrics and Gynecology</subject><subject>Ovarian cancer</subject><subject>Ovarian Neoplasms - drug therapy</subject><subject>Ovarian Neoplasms - pathology</subject><subject>Ovarian Neoplasms - surgery</subject><subject>Paclitaxel - therapeutic use</subject><subject>Peritoneal Neoplasms - drug therapy</subject><subject>Peritoneal Neoplasms - pathology</subject><subject>Peritoneal Neoplasms - surgery</subject><subject>Peritoneum - surgery</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Treatment Outcome</subject><issn>1553-4650</issn><issn>1553-4669</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2LFDEQxYMo7rr6D3iQvnmatpL0J4iwDH4sDMyCepSQTiqSNt1pk_TA_PemmXUPHjxVFbz34P2KkNcUSgq0eTeW42R_lgwoLaEpAeon5JrWNd9VTdM_fdxruCIvYhwBeAvQPCdXjHbAm4Zdkx8Hucjgo_KLVcXdnIJcMNjkZ5SuuPchFfdOKpxwToXxoTguyU7SuXOxPycfUK8KdXGrT3LeluNJBivnYr-d4SV5ZqSL-Oph3pDvnz5-23_ZHY6f7_a3h52qKKRdJ1sztAa0rPtOd6ofjB7MoLlu-qqtoUXDB6Ur4Nz0umuh1gNlLPcxppId8hvy9pK7BP97xZjEZKNC5-SMfo2i6-qe0pqyrGQXpcqlY0AjlpD7hLOgIDaqYhQbVbFRFdCITDWb3jzEr8OE-tHyF2MWvL8IMJc8WQwiKosbEBtQJaG9_X_-h3_sytnZKul-4Rnj6NcwZ3yCisgEiK_bX7e3UpoRsKrifwBxY58i</recordid><startdate>20110901</startdate><enddate>20110901</enddate><creator>Janco, Jo Marie Tran, MD</creator><creator>Hacker, Michele R., ScD, MSPH</creator><creator>Konstantinopoulos, Panagiotis A., MD</creator><creator>Cannistra, Stephen A., MD</creator><creator>Awtrey, Christopher S., MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110901</creationdate><title>Laparoscopic Intraperitoneal Port Placement for Optimally Cytoreduced Advanced Ovarian Cancer</title><author>Janco, Jo Marie Tran, MD ; Hacker, Michele R., ScD, MSPH ; Konstantinopoulos, Panagiotis A., MD ; Cannistra, Stephen A., MD ; Awtrey, Christopher S., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c410t-8a7fb7f0da598d8c9bfdbfbd3d6947507ef3bcd4033f9d8705db122003ff4a8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Catheters, Indwelling</topic><topic>Cisplatin - therapeutic use</topic><topic>Fallopian Tube Neoplasms - drug therapy</topic><topic>Fallopian Tube Neoplasms - pathology</topic><topic>Fallopian Tube Neoplasms - surgery</topic><topic>Female</topic><topic>Humans</topic><topic>Infusions, Parenteral</topic><topic>Intraperitoneal chemotherapy</topic><topic>Laparoscopy</topic><topic>Laparoscopy - methods</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Obstetrics and Gynecology</topic><topic>Ovarian cancer</topic><topic>Ovarian Neoplasms - drug therapy</topic><topic>Ovarian Neoplasms - pathology</topic><topic>Ovarian Neoplasms - surgery</topic><topic>Paclitaxel - therapeutic use</topic><topic>Peritoneal Neoplasms - drug therapy</topic><topic>Peritoneal Neoplasms - pathology</topic><topic>Peritoneal Neoplasms - surgery</topic><topic>Peritoneum - surgery</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Janco, Jo Marie Tran, MD</creatorcontrib><creatorcontrib>Hacker, Michele R., ScD, MSPH</creatorcontrib><creatorcontrib>Konstantinopoulos, Panagiotis A., MD</creatorcontrib><creatorcontrib>Cannistra, Stephen A., MD</creatorcontrib><creatorcontrib>Awtrey, Christopher S., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of minimally invasive gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Janco, Jo Marie Tran, MD</au><au>Hacker, Michele R., ScD, MSPH</au><au>Konstantinopoulos, Panagiotis A., MD</au><au>Cannistra, Stephen A., MD</au><au>Awtrey, Christopher S., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Laparoscopic Intraperitoneal Port Placement for Optimally Cytoreduced Advanced Ovarian Cancer</atitle><jtitle>Journal of minimally invasive gynecology</jtitle><addtitle>J Minim Invasive Gynecol</addtitle><date>2011-09-01</date><risdate>2011</risdate><volume>18</volume><issue>5</issue><spage>629</spage><epage>633</epage><pages>629-633</pages><issn>1553-4650</issn><eissn>1553-4669</eissn><abstract>Abstract Study objective To evaluate complications of intraperitoneal ports placed laparoscopically as a separate procedure after initial debulking surgery for ovarian, fallopian tube, or primary peritoneal cancer. Design A retrospective case series (Canadian Task Force Classification III). Setting Inpatient, academic teaching institution. Patients Female patients of any age, at a single institution, undergoing laparoscopically-assisted intraperitoneal port placement after initial surgery for ovarian, fallopian tube, or primary peritoneal cancer from January 2001 through December 2009. Interventions Laparoscopically assisted intra-peritoneal port placement. Measurements/Main Results Thirty-three ports were successfully placed, with no conversions to laparotomy. Only 2 patients were unable to receive intraperitoneal chemotherapy, and there was 1 major complication (enterotomy) related to port placement. There were 6 cases of port dysfunction (17%); however, in 3 cases the port was replaced and subsequently functioned well. There were 2 cases of port infection necessitating port removal. The majority (81.8%) of patients were able to complete all planned cycles of intraperitoneal chemotherapy. Conclusion Based on the data from our institution, laparoscopic placement of an intraperitoneal port may be safely performed as a second procedure after initial surgery for stage III ovarian, fallopian tube, or primary peritoneal cancer and provides access for post-operative therapy.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>21803662</pmid><doi>10.1016/j.jmig.2011.06.005</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1553-4650
ispartof Journal of minimally invasive gynecology, 2011-09, Vol.18 (5), p.629-633
issn 1553-4650
1553-4669
language eng
recordid cdi_proquest_miscellaneous_885911512
source MEDLINE; Elsevier ScienceDirect Journals
subjects Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Catheters, Indwelling
Cisplatin - therapeutic use
Fallopian Tube Neoplasms - drug therapy
Fallopian Tube Neoplasms - pathology
Fallopian Tube Neoplasms - surgery
Female
Humans
Infusions, Parenteral
Intraperitoneal chemotherapy
Laparoscopy
Laparoscopy - methods
Middle Aged
Neoplasm Staging
Obstetrics and Gynecology
Ovarian cancer
Ovarian Neoplasms - drug therapy
Ovarian Neoplasms - pathology
Ovarian Neoplasms - surgery
Paclitaxel - therapeutic use
Peritoneal Neoplasms - drug therapy
Peritoneal Neoplasms - pathology
Peritoneal Neoplasms - surgery
Peritoneum - surgery
Retrospective Studies
Surgery
Treatment Outcome
title Laparoscopic Intraperitoneal Port Placement for Optimally Cytoreduced Advanced Ovarian Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T02%3A25%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Laparoscopic%20Intraperitoneal%20Port%20Placement%20for%20Optimally%20Cytoreduced%20Advanced%20Ovarian%20Cancer&rft.jtitle=Journal%20of%20minimally%20invasive%20gynecology&rft.au=Janco,%20Jo%20Marie%20Tran,%20MD&rft.date=2011-09-01&rft.volume=18&rft.issue=5&rft.spage=629&rft.epage=633&rft.pages=629-633&rft.issn=1553-4650&rft.eissn=1553-4669&rft_id=info:doi/10.1016/j.jmig.2011.06.005&rft_dat=%3Cproquest_cross%3E885911512%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=885911512&rft_id=info:pmid/21803662&rft_els_id=S1553465011003244&rfr_iscdi=true